Elevance Health Directors Stock‑Buy Frenzy: Insider Kabeer Buys 11,560 Shares, Betting on Near‑Term Upside Amid Mixed Executives’ Sales
Elevance Health insider buys reveal board confidence in near‑term growth, mixed signals, and strategic focus on Medicare and employer plans—what investors should watch.
3 minutes to read


